Compound Detail
CHEMBL5953300
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5953300 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | TYRODWLXPZYVKN-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
446.5
MW (Da)
2.23
ALogP
9
HBA
2
HBD
145.1
PSA (Ų)
0.44
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 7.94
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Epidermal growth factor receptor CHEMBL203 | IC50 | 7.94 | 7.94 | 11.4 | 1 |
| Tyrosine-protein kinase BTK CHEMBL5251 | IC50 | 7.88 | 7.88 | 13.2 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Epidermal growth factor receptor | IC50 | = | 11.4 | nM | 7.94 | EGFR Inhibitory Activity: With regard to the setting of the conditions for a met... | - |
| Tyrosine-protein kinase BTK | IC50 | = | 13.2 | nM | 7.88 | BTK Inhibitory Activity: With regard to the setting of the conditions for a meth... | - |
Data from ChEMBL 36 via Core Engine